Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Pradaxa cleared for new indications in Europe

Boehringer drug set for use in deep vein thrombosis and pulmonary embolism

- PMLiVE

GSK takes anti-inflammatory drug into phase III as heart therapy

Studies losmapimod’s potential in acute coronary syndrome

- PMLiVE

Halozyme to resume pancreatic cancer study

FDA says PEGPH20 trial can continue

- PMLiVE

New president at Bayer Healthcare

Dieter Weinand replaces departing Andreas Fibig

- PMLiVE

Otsuka launches European ADPKD forum

Aims to lead awareness raising plans for rare genetic condition

Lucid expands with new London office

UK med ed agency opens doors in Hammersmith

- PMLiVE

AFFiRiS claims a first in Alzheimer’s disease therapy

Says AD04 is first drug to demonstrate disease modification

- PMLiVE

Boehringer aims for nintedanib approval in lung fibrosis by year end

EMA grants accelerated assessment to drug in rare disease

- PMLiVE

EC approves Janssen rare blood disorder drug

Sylvant available to treat multicentric Castleman's disease

- PMLiVE

Omnicom’s DAS appoints president of Europe

Emma Sergeant joins from Ogilvy Healthworld

- PMLiVE

AstraZeneca backs mental health campaign

Pharma company supports Mental Health America

- PMLiVE

Pfizer appoints diabetes expert Morris Birnbaum

He takes up post as chief scientific officer for cardiovascular and metabolic diseases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links